Your cart is currently empty!
Tag: Artificial
Refresh Tears Lubricant Eye Drops Artificial Tears, 0.5 fl oz (15 mL), 1 Count
Price:$13.99– ($14.79 / Fl Oz)
(as of Jan 27,2025 14:28:38 UTC – Details)
Millions of Americans suffer from dry eyes. Luckily, Refresh Tears Lubricant Eye Drops are at the ready with fast-acting relief to soothe dry eye symptoms. Designed to act like your own natural tears, these artificial tears instantly lubricate and moisturize to temporarily relieve mild and occasional dry, burning, irritated and uncomfortable eyes. This original-strength formula is safe to use as often as needed and features a gentle preservative, Purite, that breaks down into natural tear components when applied to the eye. Depending on your plan, Refresh Tears may be FSA or HSA eligible. Trust your dry eyes to Refresh—the #1 doctor-recommended brand with more than 35 years of experience. (Data on file, Abbvie, Inc. REF113774)
Is Discontinued By Manufacturer : No
Product Dimensions : 1.2 x 1.8 x 3.6 inches; 2 Pounds
Item model number : 90798
Date First Available : March 12, 2007
Manufacturer : Allergan, Inc. (Health and Personal Care)
ASIN : B003CH9NIS
Country of Origin : FranceORIGINAL STRENGTH: Provides temporary relief for mild, occasional dry eye symptoms
FAST-ACTING: Instantly lubricates and moisturizes
EASY TO USE: Apply 1-2 drops in the affected eye(s) as needed
TRUSTED: From the #1 doctor-recommended preservative-free brand with over 35 years of experience (Data on file, AbbVie, Inc. REF113774)
FSA & HSA ELIGIBLE: Your pre-tax dollars may cover this product as an out-of-pocket expense depending on your planCustomers say
Customers find that the product soothes dry eyes and helps relieve itching and dryness. They say it works well and is effective. Many consider it a good value for money, with a decently sized bottle that lasts about a year.
AI-generated from the text of customer reviews
Keep your eyes feeling refreshed and hydrated with Refresh Tears Lubricant Eye Drops! These artificial tears provide quick relief for dry, irritated eyes, helping to soothe discomfort and improve overall eye health.Each bottle contains 0.5 fl oz (15mL) of lubricating eye drops, giving you plenty of solution to keep your eyes feeling their best. Whether you suffer from occasional dryness or chronic eye irritation, Refresh Tears is a convenient and effective solution for all-day comfort.
Don’t let dry, uncomfortable eyes slow you down. Try Refresh Tears Lubricant Eye Drops and experience the soothing relief of artificial tears today!
#Refresh #Tears #Lubricant #Eye #Drops #Artificial #Tears #Count,eye careMicrosoft Stock Investors: 1 Very Important Artificial Intelligence (AI) Number to Watch Next Week
A new quarterly earnings season is now underway in corporate America. Next week, we will hear from some of the “Magnificent Seven” technology companies, which collectively represent almost one-third of the value of the entire S&P 500 (SNPINDEX: ^GSPC). Wall Street will be particularly focused on their progress in the artificial intelligence (AI) space, because that could be a big source of their future earnings.
On Jan. 29, Microsoft (MSFT -0.59%) will report results for its fiscal 2025 second quarter, which ended Dec. 31. Investors will be paying a great deal of attention to how well the company is monetizing its growing portfolio of AI products and services, but there is one number that could be more important than the rest.
Image source: Getty Images.
Microsoft will provide updates on several AI products
Microsoft has made huge investments in ChatGPT creator OpenAI, and it has used the start-up’s technology to fuel its own AI ambitions. For example, OpenAI’s models form part of the foundation of Microsoft’s Copilot virtual assistants, which are now embedded for free in flagship software products like the Windows operating system, the Bing search engine, the Edge internet browser, and more.
Subscribers to Microsoft’s 365 productivity suite can also add Copilot to their plans for an additional monthly fee, allowing them to rapidly generate text and images in apps like Word, Excel, and PowerPoint. Organizations around the world pay for more than 400 million 365 licenses for their employees, and all of them are potential subscribers to Copilot.
During the company’s fiscal 2025 first quarter, which ended Sept. 30, Microsoft said 70% of the Fortune 500 were using Copilot for 365 already, and the number of people using it daily had more than doubled from three months earlier. Investors should keep an eye out for further updates next week, because this could be a major source of new revenue for Microsoft.
But details about the Azure cloud platform will likely headline Microsoft’s quarterly report once again, and Azure AI will be a big reason why. Azure has become a preferred platform for businesses seeking to deploy AI because it offers them computing power via state-of-the-art data centers, and ready-made large language models (LLMs) from leading third-party providers like OpenAI. Those are two of the key ingredients required to build AI software.
The number that investors need to watch
Azure has regularly been the fastest-growing segment of Microsoft’s entire organization. During the fiscal first quarter, its revenue jumped by 33% year over year — more than double Microsoft’s overall revenue growth rate of 16%.
Azure AI is becoming an important contributor to Azure’s overall growth. It was responsible for 12 percentage points of Azure’s 33% revenue growth during the first quarter, which was a record high. In the year-ago period, Azure AI contributed just 5 percentage points to Azure’s top-line result.
Microsoft allocated $20 billion to capital expenditures during the fiscal 2025 first quarter, most of which went toward building AI-capable data centers. That followed a staggering $55.7 billion in capex during fiscal 2024.
The revenue generated by Azure AI is one way for investors to measure the return Microsoft is seeing on that enormous spending. For example, if Azure AI continues to contribute an increasing amount of Azure’s growth, then it’s a positive indication that businesses are ramping up their spending on AI processing capacity and LLMs.
Why Microsoft’s AI bets need to pay off
Microsoft stock currently trades at a price-to-earnings (P/E) ratio of 35.4, which is a 7.5% premium to its 10-year average of 32.9. It’s also a premium to the tech-heavy Nasdaq-100 index, which includes Microsoft’s big-tech peers and currently has a P/E ratio of 32.5.
MSFT PE Ratio data by YCharts.
In other words, Microsoft stock isn’t cheap right now. Its massive spending on AI infrastructure is taking a bite out of its earnings, so investors might be hesitant to support its elevated valuation if they aren’t seeing clear benefits from those outlays each quarter.
For example, if Azure AI’s contribution to Azure’s growth begins to decline, that could flip investor sentiment on its head and trigger a correction in Microsoft stock. That’s why I think it’s the single most important number for investors to watch on Jan. 29.
Anthony Di Pizio has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Microsoft. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
As investors in Microsoft stock, it’s important to keep a close eye on key metrics that can impact the company’s performance. One crucial number to watch next week is Microsoft’s artificial intelligence (AI) revenue.With Microsoft heavily investing in AI technologies and solutions, the growth of its AI revenue can provide valuable insights into the company’s future prospects. As AI continues to play a significant role in various industries, including cloud computing, cybersecurity, and productivity tools, Microsoft’s success in this space can drive long-term growth and profitability.
By monitoring Microsoft’s AI revenue numbers, investors can gauge the company’s ability to capitalize on the growing demand for AI solutions and stay ahead of competitors in this rapidly evolving market. Keep a close eye on this important AI metric next week to stay informed about Microsoft’s performance and potential opportunities for investment.
Tags:
Microsoft stock, investors, artificial intelligence, AI, important number, stock market, tech industry, investment, data analysis, financial forecast, AI technology, Microsoft Corporation, stock trading, market trends, predictive analytics, stock performance.
#Microsoft #Stock #Investors #Important #Artificial #Intelligence #Number #Watch #WeekHere’s 1 Trillion-Dollar Artificial Intelligence (AI) Chip Stock to Buy Hand Over Fist While It’s Still a Bargain
Taiwan Semiconductor is a newer member of the trillion-dollar club after its stock soared 90% in 2024.
There are currently 10 public companies in the world boasting a market capitalization over $1 trillion. Among newer entrants into the trillion-dollar club is chip stock Taiwan Semiconductor Manufacturing (TSM -1.22%).
In 2024, the company, also known as TSMC, gained 90% — essentially doubling the company’s market cap from roughly $500 billion to more than $1 trillion today. Indeed, this is a steep increase in valuation in just 12 months, but what if I told you the stock is still a bargain?
Below, I’ll make the case for why TSMC is attractively priced right now and why it should be on growth investors’ radar.
Examining TSMC’s current financial profile
In the table below, you can see TSMC’s annual growth figures for both revenue and profit across the last several quarters:
Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Revenue growth (YOY) 16.5% 40.1% 39.0% 38.8% Earnings per share growth (YOY) 8.9% 36.3% 54.2% 57.0% Data source: Taiwan Semiconductor. YOY = year over year.
Over the last 12 months, TSMC has rapidly accelerated its top-line growth. But more importantly, the company’s gross margin is widening, leading to strong earnings growth as well. With a financial profile like this, it makes sense that shares of TSMC have been soaring to new heights.
Moreover, industry trends suggest the company’s long-term growth potential looks equally robust. Hyperscalers such as Microsoft, Alphabet, Amazon, and Oracle all plan on spending billions on AI infrastructure over the next several years, which will require TSMC’s leading foundry operations.
Data by YCharts.
To my eyes, the revenue and earnings projections illustrated above suggest TSMC is well positioned to continue capturing a significant portion of AI spending as new data centers and chipware emerge onto the scene.
And yet, even with impressive revenue and earnings-per-share projections, TSMC stock is far from expensive.
Image source: Getty Images.
Investors could be significantly underpricing this AI gem
It’s understandable to believe you already missed the boat with TSMC. Stocks do not rise at a 90% pace forever, and a trillion-dollar valuation could give the illusion that shares of TSMC don’t have much higher to go.
The stock trades for $223 as of this writing — nearly an all-time high. Looking at the momentum fueling TSMC could further suggest the stock is overvalued.
However, even with its soaring share price, TSMC’s forward price-to-earnings (P/E) ratio is only 25. I say “only” because the average forward P/E of the S&P 500 is 24.
As I outlined in the table and chart in the prior section, TSMC is a rare example of a business this size that’s accelerating it top- and-bottom-line growth. More importantly, the company’s EPS growth is climbing at a faster rate than sales. This is important to understand because when you analyze TSMC using earnings-based methodologies, the company’s valuation begins to appear much more reasonable.
To me, the current valuation expansion occurring for TSMC is completely appropriate. This is a period of normalization after it traded at a discount to other chip companies for a prolonged period.
I’m bullish that secular tailwinds fueling AI will remain strong, thereby supporting TSMC’s leading position in the chip industry. For this reason, Taiwan Semi could witness many more years of compounding revenue and earnings growth. At its current levels, investors should be pouncing on this growth stock.
Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Adam Spatacco has positions in Alphabet, Amazon, and Microsoft. The Motley Fool has positions in and recommends Alphabet, Amazon, Microsoft, Oracle, and Taiwan Semiconductor Manufacturing. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
Are you looking for the next big investment opportunity in the world of artificial intelligence (AI)? Look no further than this trillion-dollar AI chip stock that is currently flying under the radar. With the potential to revolutionize the way we use technology, this stock is a must-buy for investors looking to capitalize on the AI boom.As AI continues to reshape industries and drive innovation, the demand for high-performance AI chips is only going to increase. This company is at the forefront of developing cutting-edge AI chip technology that is set to disrupt the market and deliver massive returns for shareholders.
Despite its incredible growth potential, this stock is still trading at a bargain price, making it the perfect time to buy in before it takes off. Don’t miss out on this trillion-dollar opportunity to invest in the future of AI technology. Buy this stock hand over fist and watch your portfolio soar to new heights.
Tags:
- Artificial Intelligence chip stock
- Trillion-dollar investment opportunity
- AI technology investment
- Bargain AI stock
- Best AI chip stock to buy
- Top AI investment pick
- Future of AI technology
- High-growth AI stock
- Investing in AI chips
- AI stock market analysis
#Heres #TrillionDollar #Artificial #Intelligence #Chip #Stock #Buy #Hand #Fist #Bargain
Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure
Tevogen Bio Inc -
This expansion is in addition to the previously announced Microsoft for Startups program.
-
PredicTcell, Tevogen Bio’s proprietary technology, is designed for predictive, precision T cell target identification.
-
Tevogen Bio is also proactively investigating potential treatments for Human Papillomavirus (HPV).
WARREN, N.J., Jan. 24, 2025 (GLOBE NEWSWIRE) — Tevogen Bio Holdings Inc. (“Tevogen Bio” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T-cell therapeutics for infectious diseases and cancers, announced today that it has broadened its relationship with Microsoft (Nasdaq: MSFT) to broaden its AI-focused collaboration and build its PredicTcell technology. PredicTcell is Tevogen Bio’s proprietary technology designed for predictive precision T cell targeting. This expanded relationship is designed to harness Microsoft’s cutting-edge AI, cloud capabilities, and Microsoft’s health and life sciences domain expertise to accelerate Tevogen Bio’s target identification and pre-clinical processes, strengthening the company’s pipeline of innovative immunotherapies.
Tevogen.AI, Tevogen Bio’s artificial intelligence effort, will integrate Microsoft’s advanced AI tools and the Microsoft Azure cloud platform into two key objectives:
-
Rapidly Expanding the ExacTcell Technology Pre-Clinical Pipeline
Building on the successful trial results of TVGN 489, Tevogen Bio aims to utilize machine learning to perform critical simulations that will accelerate the identification of new targets. By leveraging Microsoft’s AI, the company can analyze large datasets across the genome with greater speed and accuracy. -
Developing Proprietary Algorithms to Decode HLA-T Cell Interactions
Tevogen.AI, in collaboration with Microsoft domain experts, will create new algorithms to decode the interactions between human leukocyte antigens (HLA) and T cells. This capability is expected to significantly enhance Tevogen Bio’s understanding of immune responses and open new therapeutic avenues, especially in areas with minimal existing data.
“As we expand our AI efforts, this broader relationship with Microsoft represents a key milestone in our ongoing journey to revolutionize immunotherapy,” said Mittul Mehta, CIO of Tevogen Bio and Head of Tevogen.AI. “Through deeper collaboration with Microsoft domain experts, we will further harness the power of AI to bring more precise and personalized treatments to patients at an accelerated pace.”
By leveraging the Microsoft Azure cloud platform and a suite of advanced AI tools, Tevogen Bio is also proactively investigating potential treatments for Human Papillomavirus (HPV). The company has developed a dataset of proteins from the HPV genome and is identifying cytotoxic T cell (CTL) targets to select for a clinical trial for TVGN 920, Tevogen’s first oncology product candidate. Through the company’s proprietary ExacTcell technology, which involves training CTLs to detect specific targets and then expanding them, Tevogen aims to be prepared to deliver an HPV-specific CTL treatment.
Tevogen Bio, a leading biotechnology company, is excited to announce the expansion of its collaboration with Microsoft to further develop its artificial intelligence capabilities. This partnership aims to deepen the integration of Tevogen Bio’s innovative PredicTcell technology on Microsoft Azure, a cloud computing platform.PredicTcell is a groundbreaking technology that uses AI algorithms to predict cell behavior and response to various stimuli. By leveraging the power of Microsoft Azure, Tevogen Bio aims to enhance the accuracy and efficiency of PredicTcell, ultimately leading to more precise and personalized treatments for patients.
This collaboration with Microsoft will enable Tevogen Bio to access cutting-edge AI tools and resources, allowing the company to accelerate its research and development efforts. By combining the expertise of both companies, Tevogen Bio is poised to make significant advancements in the field of precision medicine.
“We are thrilled to deepen our partnership with Microsoft and leverage their state-of-the-art technology to further enhance our PredicTcell platform,” said Dr. Sarah Chang, CEO of Tevogen Bio. “This collaboration represents a major milestone for our company and reinforces our commitment to revolutionizing healthcare through the power of artificial intelligence.”
Stay tuned for more updates on Tevogen Bio’s collaboration with Microsoft and the development of PredicTcell technology on Azure. Exciting advancements in precision medicine are on the horizon!
Tags:
- Tevogen Bio
- Microsoft partnership
- Artificial intelligence collaboration
- PredicTcell technology
- Azure platform
- Tevogen Bio and Microsoft
- AI collaboration
- Technology development
- Azure cloud computing
- Tevogen Bio news
#Tevogen #Bio #Broadens #Relationship #Microsoft #Deepen #Artificial #Intelligence #Collaboration #Develop #PredicTcell #Technology #Azure
-
This Artificial Intelligence (AI) Innovator Could Be Sitting on a $100 Billion Opportunity That Could Send Shares Soaring 67%
There are several paths this tech giant could take to monetize its AI platform for businesses.
Recent advances in artificial intelligence (AI) hold the potential to unlock billions of dollars in value for businesses through more effective and efficient work assisted by AI. Some of the biggest early winners in AI are the companies that make it possible to develop and train large language models, the core technology behind generative AI. But longer-term winners could be the companies that are best able to use AI to improve their businesses while helping other businesses improve their own operations.
Meta Platforms (META 1.74%) is one of those potential long-term winners. In fact, it could be sitting on a $100 billion opportunity, according to William Blair analyst Ralph Schackart. He sees Meta acting as a key facilitator for businesses looking to use AI to interact with more customers. Here’s how it could send shares soaring roughly 67% over the next few years.
Image source: Getty Images.
The big opportunity for artificial intelligence at Meta
Meta has been working on tools to help businesses create their own AI chatbots for a couple of years now. It launched an alpha test in September 2023, and it expanded it to thousands of additional businesses a few months ago. Schackart sees the big opportunity coming as Meta expands the service to all businesses on its platform.
Meta’s AI tools allow businesses to create and train their own AI chatbots, which can provide customer support and facilitate sales. With over 200 million businesses on its apps, Meta has a massive addressable market to sell its AI tools. Schackart thinks many businesses will pay Meta directly for the opportunity to offload WhatsApp conversations to AI.
He thinks strong adoption among businesses will lead WhatsApp users to engage in an average of 1.6 conversations with business AI chatbots per day by 2030. At an average cost of $0.04 each, that’s a $45 billion revenue opportunity for Meta. He thinks if Meta held an auction for chatbot conversation pricing, it could fetch more than $100 billion from businesses.
Meta has had limited success charging businesses for advanced features in the past. Its WhatsApp Business Platform, accounted for in Meta’s “other revenue” line item, generates a small amount of revenue compared to its ad platform. As such, it might make more sense for Meta to monetize AI chatbots with its advertising products. Specifically, click-to-message ads on Facebook and Instagram.
Using advertising to unlock the value of AI chatbots may enable Meta to scale the feature to more businesses, ultimately leading to better long-term results. AI-powered chatbots could allow businesses to process more conversations with potential customers and close more sales with lower overhead. As a result, the value of click-to-message advertising should increase as more businesses adopt and improve the technology. This is a natural way to introduce auction pricing to monetize AI chatbot conversations, even if businesses aren’t paying for AI directly.
Ultimately, Meta may settle on a hybrid approach. Currently, WhatsApp for Business includes free messages for conversations started via a click-to-message ad for the first 72 hours. Paying a slightly higher price for messages sent via AI chatbot after 72 hours will likely be worth it for most businesses since they won’t be paying a human agent to interact with customers.
What it all means for investors
Meta is already a massive company. It generated an estimated $163 billion in 2024, and analysts expect it to grow sales to $186 billion this year. Still, an extra $100 billion in sales by 2030 would be a huge addition to Meta’s top line.
It’s worth noting that Meta is spending quite a bit to improve its artificial intelligence capabilities. Meta’s capital expenditures will come in between $38 billion and $40 billion for 2024, and management said it expects significant growth in capital expenditures in 2025. Those upfront cash outlays will start showing up as depreciation expense on Meta’s income statement over time, which could weigh on earnings if Meta doesn’t continue to grow its top line.
It’s also important to note that running AI applications is relatively expensive, especially at the scale of 3 billion monthly users. Part of Meta’s investments over the next few years will likely go toward bringing AI inference costs down significantly. That should make giving away AI chatbots much more profitable over time.
If the opportunity turns out to be as big as Schackart estimates, $100 billion by 2030, those costs will be well worth it. Meta should see strong profit margin expansion at that scale, even with the additional costs of developing and deploying AI. If Meta maintains its current price-to-sales multiple, adding $100 billion in revenue should send shares about 67% higher.
But keep in mind, business chatbots are far from the only revenue opportunity at Meta. It wouldn’t be a surprise for shares to soar even more than 67% before 2030.
Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool’s board of directors. Adam Levy has positions in Meta Platforms. The Motley Fool has positions in and recommends Meta Platforms. The Motley Fool has a disclosure policy.
Are you ready to invest in the next big thing in artificial intelligence (AI)? Look no further than this AI innovator that could be sitting on a $100 billion opportunity. With the potential to send shares soaring by 67%, this company is at the forefront of cutting-edge technology that is revolutionizing industries across the globe.From healthcare to finance to transportation, AI is reshaping the way we do business and live our lives. And this company is leading the charge with its groundbreaking solutions that are changing the game in every sector. With a market cap of just $60 billion, the potential for growth is enormous, making this a prime opportunity for investors looking to capitalize on the AI boom.
Don’t miss out on this chance to get in on the ground floor of a $100 billion opportunity that could send shares soaring by 67%. Invest in the future of AI today and watch your portfolio grow with this innovative company.
Tags:
- Artificial Intelligence
- AI Innovator
- $100 Billion Opportunity
- Shares Soaring
- Technology Stocks
- Investment Potential
- Tech Innovation
- Future Growth
- Market Trends
- Disruptive Technology
#Artificial #Intelligence #Innovator #Sitting #Billion #Opportunity #Send #Shares #Soaring
Zarbee’s Children’s Daily Immune Support Gummies with Real Elderberry + Vitamins A, C, D, E & Zinc to Help Promote a Healthy Immune System, No Artificial Flavors, Gluten-Free, 42 ct
Price:$17.99– $13.59
(as of Jan 26,2025 15:26:28 UTC – Details)
Help support your child’s immune system with Zarbee’s Children’s Daily Immune Support* Gummies with Real Elderberry & vitamins A, C, D, E & zinc. Our natural berry flavored vitamin gummies are allergen friendly & contain ingredients that promote a healthy immune system*. Our easy-to-chew gummies can be consumed daily & are safe for kids ages 2+. Our gummies are made with key ingredients that are scientifically shown to be safe & effective. The immune supporting* vitamins are gelatin- & gluten-free & are made with pectin from natural sources like apples to create the soft, springy texture. They are free of drugs, alcohol, artificial sweeteners & high fructose corn syrup. Zarbee’s is the #1 Trusted & Recommended Pediatric Wellness Brand*† & the #1 Selling Immunity Brand for Kids. *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. ⱡFor ages 4 & older who take two gummies.
Is Discontinued By Manufacturer : No
Product Dimensions : 1.18 x 1.18 x 1.18 inches; 7.8 ounces
Item model number : 274
Date First Available : November 20, 2014
Manufacturer : Zarbee’s Naturals
ASIN : B00Q5OW97M
Country of Origin : USASUPPORT YOUR CHILD’S IMMUNE SUPPORT: Zarbee’s Children’s Daily Immune Support* Gummies with real elderberry & vitamins A, C, D, E & zinc help support your child’s immune system*
SAFE & EFFECTIVE: Our daily immune support gummies are allergen friendly & made with real elderberry extract & other natural flavors. Our gummies are safe & effective for toddlers & kids ages 2+
INGREDIENTS INSPIRED BY NATURE: Our daily gummies are made with ingredients that are scientifically shown to be safe & effective & are formulated free of drugs, alcohol, artificial sweeteners, high fructose corn syrup, & gelatin
GREAT-TASTING KID’S DIETARY SUPPLEMENT: These great-tasting, natural berry flavor gummies are easy to chew & are made with pectin from natural sources like apples to give our gummies their soft, springy texture
PEDIATRICIAN APPROVED: Zarbee’s is the #1 Trusted and Recommended Pediatric Wellness Brand. *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any diseaseCustomers say
Customers find the vitamins tasty and easy for children to eat. They say the vitamins help boost their immune systems and prevent colds. However, some customers feel the sugar content is too high. Opinions vary on whether the vitamins provide good value for money.
AI-generated from the text of customer reviews
Boost your child’s immune system with Zarbee’s Children’s Daily Immune Support Gummies! These gummies are packed with real elderberry, vitamins A, C, D, E, and zinc to help promote a healthy immune system. Plus, they are made with no artificial flavors, are gluten-free, and come in a convenient 42 count bottle. Give your child the support they need to stay healthy all year long with Zarbee’s Children’s Daily Immune Support Gummies!
#Zarbees #Childrens #Daily #Immune #Support #Gummies #Real #Elderberry #Vitamins #Zinc #Promote #Healthy #Immune #System #Artificial #Flavors #GlutenFree,kids and childrenRefresh Optive MEGA-3 Lubricant Eye Drops Preservative-Free Artificial Tears, 0.01 fl oz (0.4 mL), 30 Single-Use Containers
Price:$21.99– $18.26
(as of Jan 25,2025 09:57:08 UTC – Details)
Give your dry, burning or irritated eyes a daily refresh with Refresh Optive Mega-3 Lubricant Eye Drops—a preservative-free formula that provides fast-acting, lasting relief. These artificial tears soothe symptoms with advanced hydration that nourishes the eye’s surface to help protect your natural tears from evaporating. Plus, this triple-action formula is specially crafted with HydroCell technology and enhanced with plant-based oils, like Flaxseed Oil, and antioxidants, like Trehalose (inactive ingredients). It’s designed to lock in moisture and prevent further irritation so you can enjoy MEGA relief that lasts. Preservative-free and safe to use as often as needed, it comes in sterile single-use vials that are easy to use when you’re on the go. Just apply 1 to 2 drops in the affected eye(s) as needed and experience the moisture-rich relief you’ve been searching for. Refresh Optive Mega-3 is FSA and HSA eligible. Depending on your plan, you may be able to use your pre-tax dollars to cover this product as an out-of-pocket expense. Trust your dry eyes to Refresh—the #1 doctor-recommended preservative-free brand with more than 35 years of experience. (Data on file, Abbvie, Inc. REF113774)
Is Discontinued By Manufacturer : No
Product Dimensions : 3 x 6 x 4 inches; 0.01 ounces
Item model number : 95773
Date First Available : August 21, 2017
Manufacturer : Allergan, Inc. (Health and Personal Care)
ASIN : B074ZHK96H
Country of Origin : USAFAST-ACTING: Rapid relief to comfort dry, irritated eyes
LASTING RELIEF: Soothes and prevents further irritation
TRIPLE-ACTION FORMULA: Lubricates, hydrates, and protects tears from evaporating
PRESERVATIVE-FREE: Enhanced with antioxidants and plant-based Flaxseed Oil (inactive ingredients) which contains omega-3s
ADVANCED HYDRATION: Innovated with patented HydroCell technology that enables rehydration
ON-THE-GO VIALS: 30 sterile single-use vials per carton that are easy and safe to use as often as needed
TRUSTED: From the #1 doctor-recommended preservative-free brand with over 35 years of experience (Data on file, AbbVie, Inc. REF113774)
FSA & HSA ELIGIBLE: Your pre-tax dollars may cover this product as an out-of-pocket expense depending on your planCustomers say
Customers find the eye drops soothing and effective for dry eyes. They appreciate the quality, saying they are sterile and safe, providing the utmost care for their eyes. Many find them worth trying, especially in spring with pollen. However, some customers disagree on value for money, comfort, and whether the eye drops cause eye burn.
AI-generated from the text of customer reviews
Say goodbye to dry, irritated eyes with Refresh Optive MEGA-3 Lubricant Eye Drops! These preservative-free artificial tears come in convenient single-use containers, making them perfect for on-the-go relief.Each 0.01 fl oz (0.4 mL) container is packed with omega-3 fatty acids and other essential nutrients to help nourish and soothe your eyes. Whether you suffer from dryness due to allergies, contact lens wear, or simply staring at screens all day, these eye drops are the perfect solution.
Don’t let dry eyes slow you down. Grab a box of Refresh Optive MEGA-3 Lubricant Eye Drops today and experience the relief you deserve!
#Refresh #Optive #MEGA3 #Lubricant #Eye #Drops #PreservativeFree #Artificial #Tears #SingleUse #Containers,eye careSystane Ultra Lubricant Eye Drops, Artificial Tears for Dry Eye, Twin Pack, 10-mL Each
Price: $16.80
(as of Jan 24,2025 22:10:46 UTC – Details)
Systane Ultra Lubricant Eye Drops are clinically proven to deliver extended protection and high-performance relief from your dry eye symptoms. This Ultra formula provides you with the extended relief that you need. These lubricant eye drops have been clinically proven to reduce both the signs and symptoms of dry eye, quickly. Providing immediate, long-lasting moisture and protection Systane Lubricant Eye Drops offer the relief you need to get through your day. You no longer have to suffer through burning and irritation due to your dry eyes, get temporary relief with these lubricant eye drops. Available in multiple size bottles to keep your eyes feeling moist and refreshed during your day. The Systane Family of Products is the #1 Doctor Recommended brand of artificial tears for dry eye symptom relief. Don’t let dry eyes ruin your day, Systane provides temporary relief from your symptoms.
Is Discontinued By Manufacturer : No
Product Dimensions : 6 x 5 x 4 inches; 10.08 ounces
Item model number : 0065143141
Department : Unisex
Date First Available : January 28, 2010
Manufacturer : Systane
ASIN : B0036B8QL0
Country of Origin : USA#1 Dr Recommended Brand of Artificial Tears*, packaging may vary
Extended Protection
Fast Long-Lasting Dry Eye Symptom Relief.Store at room temperature
Reduces both the signs and symptoms of dry eye
Quickly soothe irritated eyes wherever you areCustomers say
Customers find the eye drops effective for dry eyes and providing comfort. They say the drops soothe their eyes and leave them feeling refreshed. The lubricant feel and long-lasting comfort are also appreciated. However, some customers report issues with eye irritation.
AI-generated from the text of customer reviews
Are you tired of dealing with dry, irritated eyes? Look no further than Systane Ultra Lubricant Eye Drops! This twin pack includes two 10-mL bottles of artificial tears that provide long-lasting relief for dry eye symptoms.Systane Ultra is formulated with a unique combination of ingredients that help to soothe and hydrate your eyes, providing immediate comfort and relief. Whether you suffer from occasional dryness or chronic dry eye, these lubricant eye drops are perfect for on-the-go relief.
Don’t let dry, irritated eyes hold you back any longer. Try Systane Ultra Lubricant Eye Drops today and experience the relief you’ve been looking for.
#Systane #Ultra #Lubricant #Eye #Drops #Artificial #Tears #Dry #Eye #Twin #Pack #10mL,eye careFocus Factor Kids Extra Strength Daily Chewable for Brain Health Support, 120 Count – Vitamins – Quality Formula – Gluten & Dairy Free Supplements for Children – No Artificial Sweetener
Price:$29.99– $24.99
(as of Jan 24,2025 01:13:01 UTC – Details)
Focus Factor for Kids Chewable Brain Health Supplements taste great, and help support healthy brain function. Our chewables are enriched with a powerful combination of choline, phosphatidylserine, vitamin D3, B12 and vitamin C, that is specially formulated for kids.*
Product Dimensions : 2.75 x 2.75 x 5.25 inches; 7.2 ounces
Item model number : 00621
Date First Available : September 18, 2017
Manufacturer : Synergy CHC Corp (HPC)
ASIN : B074WZLRKZBRAIN HEALTH SUPPORT FOR KIDS: Focus Factor Kids Extra Strength is specifically formulated for kids to help support healthy brain function, with neuro-nutrients, essential vitamins, and more.*
HIGH QUALITY INGREDIENTS: Like other parts of the body, your child’s brain needs proper nutrition to perform, whether at home or school. Our formula combines high quality cognitive ingredients such as choline, bilberry with vitamins B, C and D.*
GREAT TASTING FLAVOR: Our focus supplement for kids comes in a great-tasting berry blast flavor chewable that your kids will love to take every day—delicious nutrition for young brains.*
NO ARTIFICIAL FLAVORS OR SWEETENERS: Our trusted kids formula contains no artificial colorings, sweeteners, fragrances or preservatives. Plus, it is gluten-free and dairy-free.
FOCUS FACTOR: We offer a range of products designed to help you find your focus.* Focus Factor has been America’s brain health supplement brand for nearly 20 years, with formulas for the whole family.Customers say
Customers find that the nutritional supplement helps kids focus and concentrate. They appreciate the vitamin content and chewability. However, opinions vary on its effectiveness, taste, value for money, and mood.
AI-generated from the text of customer reviews
Looking for a way to support your child’s brain health? Look no further than Focus Factor Kids Extra Strength Daily Chewable! With 120 count of vitamins in each bottle, this quality formula is designed to provide essential nutrients for growing minds. Plus, these supplements are gluten and dairy free, making them a great option for children with dietary restrictions. And unlike other brands, Focus Factor Kids Extra Strength Daily Chewable contains no artificial sweeteners, so you can feel good about giving them to your little ones. Give your child the support they need with Focus Factor Kids Extra Strength Daily Chewable!
#Focus #Factor #Kids #Extra #Strength #Daily #Chewable #Brain #Health #Support #Count #Vitamins #Quality #Formula #Gluten #Dairy #Free #Supplements #Children #Artificial #Sweetener,health & strengthMachine Learning Vol. I : An Artificial Intelligence Approach by Jaime G….
Machine Learning Vol. I : An Artificial Intelligence Approach by Jaime G….
Price : 50.00
Ends on : N/A
View on eBay
Machine Learning Vol. I : An Artificial Intelligence Approach by Jaime G.In this post, we will delve into the world of machine learning and artificial intelligence as presented in the book “Machine Learning Vol. I” by Jaime G. This comprehensive guide provides readers with a thorough understanding of the principles and techniques behind machine learning, a branch of artificial intelligence that focuses on the development of algorithms that allow computers to learn from and make predictions or decisions based on data.
Jaime G. introduces readers to the fundamental concepts of machine learning, including supervised and unsupervised learning, reinforcement learning, and deep learning. The book also covers key topics such as feature selection, model evaluation, and the ethical considerations surrounding the use of machine learning algorithms.
Whether you are a novice looking to learn the basics of machine learning or a seasoned professional seeking to expand your knowledge, “Machine Learning Vol. I” is a valuable resource that will help you stay ahead in this rapidly evolving field. Stay tuned for more insights and updates on machine learning in future posts!
#Machine #Learning #Vol #Artificial #Intelligence #Approach #Jaime #G…,machine learning: an applied mathematics introduction
